The gut microbiome has been increasingly recognised as crucial to health and has been shown to be disrupted in such diverse diseases and conditions as cardiovascular disease, renal disease, liver disease, lung infections, osteoarthritis. In addition, the microbiome-gut-brain axis has been shown to be a vital link in the neurological and neurodegenerative disorders of Alzheimer’s disease, Parkinson’s disease, autism spectrum disorder and depression. We have previously demonstrated the effect that PBM can have on the microbiome of healthy mice. In this presentation, results from a number of case studies from human trials will be presented, suggesting the potential of PBM to influence the microbiome in a positive manner. These changes correspond to improvements in a number of measures of human health in cancer treatment, Parkinson’s disease and metabolic syndrome. The interaction between light and the microbiome will be explored.
|